Icure Pharmaceutical Incorporation
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
175250 | KO
Overview
Corporate Details
- ISIN(s):
- KR7175250000
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 봉은사로104길 10 7층, 강남구
- Website:
- https://www.icure.co.kr/eng/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Icure Pharmaceutical Incorporation is a biopharmaceutical company specializing in the research, development, and commercialization of products based on its Transdermal Drug Delivery System (TDDS) technology. Established in 2000, the company develops innovative new drugs, including transdermal patches for dementia and Parkinson's disease. Icure also operates a cosmeceutical business, leveraging its pharmaceutical expertise to offer Original Design Manufacturing (ODM) and Original Brand Manufacturing (OBM) services for cosmetics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상 결정)
|
Korean | 4.9 KB | ||
| 2025-09-17 00:00 |
Delisting Announcement
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
|
Korean | 4.7 KB | ||
| 2025-09-16 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-08-27 00:00 |
Regulatory News Service
기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)
|
Korean | 3.2 KB | ||
| 2025-08-22 00:00 |
Capital/Financing Update
주요사항보고서(자기전환사채만기전취득결정)
|
Korean | 14.7 KB | ||
| 2025-08-22 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 85.9 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.6 MB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-08-05 00:00 |
Legal Proceedings Report
횡령ㆍ배임혐의발생
|
Korean | 8.7 KB | ||
| 2025-08-05 00:00 |
Delisting Announcement
주권매매거래정지 (상장적격성 실질심사 대상 (사유발생))
|
Korean | 4.6 KB | ||
| 2025-08-05 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 관련 안내)
|
Korean | 2.7 KB | ||
| 2025-08-05 00:00 |
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
|
Korean | 3.0 KB | ||
| 2025-07-16 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 79.1 KB | ||
| 2025-07-10 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 66.8 KB | ||
| 2025-06-30 00:00 |
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
|
Korean | 9.0 KB |
Automate Your Workflow. Get a real-time feed of all Icure Pharmaceutical Incorporation filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Icure Pharmaceutical Incorporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Icure Pharmaceutical Incorporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
